Results 81 to 90 of about 24,852 (213)
Characteristics of subjects with mycosis fungoides (n = 35).
Characteristics of subjects with mycosis fungoides (n = 35).
Jie Liu (15128) +4 more
core +1 more source
Background: Mycosis fungoides is a cutaneous T-cell lymphoma. The patch stage is limited to the skin and may spontaneously involute or progress, spreading to peripheral blood, lymph nodes and viscera.
Blanca María Castillo-Morfín +1 more
doaj +1 more source
Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo
Summary Background and objectives Chronic pruritus (CP) and chronic prurigo (CPG, including prurigo nodularis) are prevalent, debilitating diseases with diverse comorbidities, including malignancies. This retrospective cohort study evaluated the prevalence and risk of lymphoma in CP and CPG patients, including key risk factors, and sex‐ and ancestry ...
Svenja Royeck +10 more
wiley +1 more source
Mycosis Fungoides With γδ Immunophenotype
This cohort study examines mycosis fungoides that expresses a γδ T-cell receptor immunophenotype.
Paola Aguilar Neuville +5 more
core +1 more source
Photoprotective practices in patients with mycosis fungoides: a questionnaire‐based survey study
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Ioannis‐Alexios Koumprentziotis +6 more
wiley +1 more source
Subcutaneous panniculitis‐like T‐cell lymphoma. Survival outcomes according to the presence of hemophagocytic lymphohistiocytosis (HLH) and T category. Relapse‐free survival was inferior in patients presenting with generalized (T3) skin lesions. Overall survival was poor in patients with HLH. Relapse‐free survival was also reduced in patients with HLH.
Myoung Eun Choi +6 more
wiley +1 more source
Background and Objective: Mycosis fungoides is a neoplastic skin disorder whose underlying cause is not yet fully understood. There are hypotheses about the possible effect of viral agents on the development of mycosis fungoids that have not yet been ...
Fatemeh Mohammadi Pasand +3 more
doaj
Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in Sézary
Taku Fujimura +7 more
doaj +1 more source
Nemolizumab for Pruritus Control in Cutaneous T‐Cell Lymphoma: A Case Series
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Yenny Angela +2 more
wiley +1 more source

